Molecular Biology Core
分子生物学核心
基本信息
- 批准号:8429454
- 负责人:
- 金额:$ 3.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdsorptionAnimalsAntibodiesAntigensAutologousBindingBiological AssayBloodChimera organismCodon NucleotidesCollaborationsConsensusDNADataEpitope MappingEpitopesEscape MutantEvolutionGenerationsGoalsHIVHIV Envelope Protein gp120HIV-1HumanImmune SeraImmunologyInfectionLengthMacacaMolecularMolecular BiologyMonkeysMonoclonal AntibodiesMutagenesisPatientsPlasmaPlasmidsPlayProtein BindingProteinsReagentResearch Project GrantsRoleSeriesSerumSiteSorting - Cell MovementTestingTimeVariantVertebral columnViralVirusWorkbasecell typedesignenv Gene Productsenv Genesexpression vectorimprovedin vivointerestmonomermutantpolyclonal antibodyprogramsresearch studyresponserev Genessimian human immunodeficiency virusvector
项目摘要
The purpose of the Molecular Biology Core is to assist the HIVRAD program in characterizing the epitopes
recognized by MAbs and polyclonal human and monkey antisera that target QNEs. The main role of this
Core will be to generate DNA and protein reagents needed by the other projects and the Viral Immunology
Core. The Specific Aims are : 1) To design and produce plasmids expressing chimeric and mutant HIV-1
Envs for epitope mapping studies and for viral neutralization assays in Projects 1, 2 and 4. 2) To generate
monomeric WT gp120 and gp140 proteins, and soluble monomers and trimers that express QNEs. These
proteins will be used for binding and adsorption studies in Projects 1, 2 and 4, and as immunogens in Project
3. These studies willl be guided by results of epitope mapping experiments obtained from Projects 1, 2 and
4. 3) To generate infectious SHIV pseudotypes and infectious mutant SHIVs with variant Envs that express
QNEs. Fragments of the SHIV Env will be cloned into appropriate vectors to facilitate mutagenesis
experiments, and the complete SHIV Env-Rev genes will be subcloned into the pcDNA 3.1 vector to
generate viral pseudotype. These will be used to allow efficient construction of Env mutants and chimeras
and for the generation of viral pseudotypes for the characterization of functional activity of the mutant SHIV
Envs. QNEs defined in Projects 1 and 2 will be introduced into the SHIV1157ip Env for characterization of
their infectivity in monkey blood PBMCs and their neutralization sensitivity. Ultimately, mutant SHIV Envs will
be introduced in the SHIV1157ip proviral backbone to generate infectious SHIVs expressing QNEs for invivo
studies described in Project 3. 4) To isolate and characterize escape mutant Envs from infected
macaques. The evolution of Env sequence in the infected animals will be investigated during the course of
infection to follow the anti-QNEs neutralizing responses and identify viral escape mutants. Envs will be
cloned and escape mutants will be identified by neutralization assays (Viral Immunology core).
分子生物学核心的目的是协助HIVRAD项目表征抗原表位
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AYMERIC DE PARSEVAL其他文献
AYMERIC DE PARSEVAL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AYMERIC DE PARSEVAL', 18)}}的其他基金
CD134-based fusion polypeptides as novel FIV immuno-therapeutics
基于 CD134 的融合多肽作为新型 FIV 免疫治疗剂
- 批准号:
7244052 - 财政年份:2006
- 资助金额:
$ 3.02万 - 项目类别:
CD134-based fusion polypeptides as novel FIV immuno-therapeutics
基于 CD134 的融合多肽作为新型 FIV 免疫治疗剂
- 批准号:
7407054 - 财政年份:2006
- 资助金额:
$ 3.02万 - 项目类别:
CD134-based fusion polypeptides as novel FIV immuno-therapeutics
基于 CD134 的融合多肽作为新型 FIV 免疫治疗剂
- 批准号:
7167861 - 财政年份:2006
- 资助金额:
$ 3.02万 - 项目类别:
相似海外基金
The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
- 批准号:
EP/Z000920/1 - 财政年份:2025
- 资助金额:
$ 3.02万 - 项目类别:
Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
- 批准号:
FT230100276 - 财政年份:2024
- 资助金额:
$ 3.02万 - 项目类别:
ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
- 批准号:
MR/X024261/1 - 财政年份:2024
- 资助金额:
$ 3.02万 - 项目类别:
Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
- 批准号:
DE240100388 - 财政年份:2024
- 资助金额:
$ 3.02万 - 项目类别:
Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
- 批准号:
2889694 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
- 批准号:
2842926 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
- 批准号:
NC/X001644/1 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
- 批准号:
2337595 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
- 批准号:
2232190 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
- 批准号:
23K17514 - 财政年份:2023
- 资助金额:
$ 3.02万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




